Dr. Myoung Ok-Kwon is an investment partner at Swisscom Ventures and leads digital health investments.
She has 20 years of experience in healthcare investment and pharma research. She has been responsible for the investment and portfolio management of over 70 biotech & health tech companies in the field of therapeutics, diagnostics, and medical devices through her involvement in VC funds and public equity funds in Switzerland and USA.
Dr. Kwon worked at Novartis and was responsible for research strategy & planning and portfolio review.
She holds a Ph.D. in biochemistry and molecular genetics from the Friedrich Miescher Institute, Novartis, and the University of Basel.